Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FDG PET/MRI for Chronic Pain
NCT03195270Phase 1Completed
- Sponsor
- Stanford University
- Start
- Nov 2014
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Stanford University. Primary endpoint: [18F]FDG PET/MRI as a spatial biomarker for chronic pain at 5 years. Started Nov 2014; status: completed.
Beyond the preview
Go deeper on NCT03195270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03195270.